Khosla Ventures on X

Khosla Ventures is a United States firm that talks about technology-based economic disruption and about standing with founders when the work still looks like a science project to everyone else. On khoslaventures.com the house describes venture assistance in Vinod Khosla’s language, publishes essays on artificial intelligence, and organises capital across a Seed Fund, a Main Fund, and an Opportunity Fund. It says it likes large problems that technology can touch, and that it looks for unfair advantages: proprietary science, unusual business models, different partnerships, and teams obsessed with a vision. Those sentences are Khosla Ventures’ own. They are not a product roadmap you can trade and not a promise that every ambitious deck will be funded. Founder quotes the site chooses to print—from teams such as Sword Health, Nutanix, and DevRev—talk about belief when others would not, and about staying through hard years. Read them as testimonials the firm selected, not as a diversified performance study. AI, in the firm’s own essay framing, is a force that could rewrite economic models; that is opinionated research, not investment advice. Official X is khoslaventures. Official LinkedIn is khosla-ventures. Official YouTube is user/khoslaventures. Those channels carry talks, fund notes, and founder colour. They are not a fundraising desk and not a place to share wire details, OTP codes, lab secrets, or cap-table files. Anyone asking for a success fee to “get you to Vinod” in a direct message is not the firm. None of this is investment advice or a solicitation to invest in the Seed, Main, or Opportunity funds. Follow official Khosla channels for the disruption-minded partnership, then verify every fund label and essay title on khoslaventures.com. Khosla Ventures also publishes “How We Work” and “How We Decide” sections next to the three fund labels. Those pages are the firm’s process colour. They are not a scoring rubric you can game in a tweet. Essays on utopia versus dystopia in AI are opinion from Vinod Khosla and the partnership, not a research report you should trade on and not a clinical guideline. If a founder story names Nutanix or Sword Health, it is a selected quote. Future funds, if announced, will appear on khoslaventures.com. Keep hardware designs, biological data, and banking passwords off the YouTube comment box.